首页> 外文OA文献 >A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans

【2h】

A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans

机译：来自基于Nevirapine的抗逆转录病毒治疗的随机切换到单片毛绒红霉/ Emtrickabine / Tenofovir Disoproxil富马酸莫特在病毒学抑制的人免疫缺陷病毒-1感染的卢旺达

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Sean E. Collins; Philip M. Grant; Francois Uwinkindi; Annie Talbot; Eric Seruyange; Deborah Slamowitz; Adeline Mugeni; Eric Remera; Simon Pierre Niyonsenga; Josbert Nyirimigabo; Jean Paul Uwizihiwe; Pierre Dongier; Ribakare Muhayimpundu; Jean-Baptiste Mazarati; Andrew Zolopa; Sabin Nsanzimana;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans [J] . Eric Remera, Andrew Zolopa, Francois Uwinkindi, Open Forum Infectious Diseases . 2016,第3期

机译：在病毒学上抑制人类免疫缺陷病毒-1感染的卢旺达人中，从基于奈韦拉平的抗逆转录病毒疗法向单片瑞吡韦林/恩曲他滨/替诺福韦富马酸二吡呋酯随机转换
2. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1 [J] . Eron Joseph J., Orkin Chloe, Cunningham Douglas, Antiviral Research . 2019,第期

机译：第9周的疗效和安全结果3阶段，随机祖母绿试验评估从增强蛋白酶抑制剂的切换加上Emtricitabine / Tenofovir Disoproxil富马酸莫霉素治疗达伦韦/钴/ Emtricitabine / Tenofovir Alafenaine的单片体方案（D / C / F / TAF）在治疗经验丰富的病毒学 - 被抑制的成年人与HIV-1一起生活
3. Stable Caloric Intake and Continued Virologic Suppression for HIV-Positive Antiretroviral Treatment-Experienced Women After Switching to a Single-Tablet Regimen of Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate [J] . Menezes Prema, Mollan Katie, Hoffman Erin, AIDS Research and Human Retroviruses . 2018,第6期

机译：稳定的热量摄入和持续的病毒学抑制艾滋病毒阳性抗逆转录病毒治疗 - 经验丰富的女性切换到Emtrickabine，瑞吉州和替诺福韦解毒富马酸莫氏菌的单片
4. A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans [O] . Sean E. Collins, Philip M. Grant, Francois Uwinkindi, 2016

机译：在病毒学上抑制人类免疫缺陷病毒-1感染的卢旺达人中从基于奈韦拉平的抗逆转录病毒疗法向单片瑞吡韦林/恩曲他滨/替诺福韦富马酸二吡呋酯随机转换
5. 1768. Efficacy and Safety of Switching From Boosted-Protease Inhibitors (bPI) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) Regimens to the Once Daily (QD), Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed, HIV-1-Infected Adults: Week 96 Results of the Phase 3, Randomized, Non-Inferiority EMERALD Trial [O] . Joseph Eron, Chloe Orkin, Douglas Cunningham, 2018

机译：1768.从增强蛋白酶抑制剂（BPI）加上Emtricisabine / Tenofovir Disoprocate（F / TDF）方案的疗效和安全性转换为曾经每日（QD），单级片剂/ Cobicistat / Emtricicabine / Tenofovir的单片植物（str）在病毒学抑制的阿拉芬酰胺（D / C / F / TAF），HIV-1感染的成人：第3周的96个结果3阶段，随机，非劣势祖母绿试验

A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans

著录项

相似文献

相关主题

期刊订阅